Description:
Molecular diagnostics is a rapidly evolving and dynamic field, representing the fastest-growing segment within the in vitro diagnostics (IVD) market. It has become an indispensable tool in clinical medicine, influencing various aspects of healthcare such as early identification of antimicrobial resistant (AMR) infections, companion diagnostics for cancer treatment, pharmacokinetics for HIV, psychiatric conditions, and blood thinners, as well as cancer prognosis, organ matching, blood safety, and diagnosis of latent and neonatal conditions. Kalorama Information’s The World Market for Molecular Diagnostics Tests, 10th Edition (NGS, PCR, NAAT, ISH, TMA, Other) provides a comprehensive analysis of the global market, segmented by application and region.
Key Features of the Report:
- Global Market Segmentation: Detailed analysis of molecular diagnostics by application segments from 2021 to 2026.
- Infectious Diseases
- Blood Screening
- Histology
- Cancer Assays
- Transplant
- Inherited Diseases
- Regional Market Breakdown: Market data for molecular diagnostics segmented by major regions.
- North America (2021-2026)
- Europe (2021-2026)
- Asia Pacific (2021-2026)
- Rest of World (2021-2026)
In-Depth Analysis by Subsegments:
- Molecular Infectious Disease Diagnostics:
- Hepatitis
- HIV
- Healthcare-Associated Infections (HAIs)/Sepsis
- Human Papillomavirus (HPV)
- Chlamydia/Gonorrhea (CT/NG)
- Respiratory Diseases
- Mycobacteria/Tuberculosis (TB)
- Molecular Blood Screening Diagnostics:
- Geographic analysis of blood screening diagnostics markets.
- Molecular Histology and Cytology Diagnostics:
- Cancer
- Inherited Diseases
- Infectious/Other
- Molecular Cancer Diagnostics:
- Tissue-based tests
- Companion assays
- Prognosis and diagnosis of specific cancer types
- Molecular Transplant Diagnostics:
- HLA gene screening
- PCR-based and bead-array-based test kits
- Growing demand for NGS technologies
- Molecular Inherited Diseases Diagnostics:
- Thrombophilia (SNP tests) & Coagulation Markers
- Non-Invasive Prenatal Testing (NIPT)
- Other inherited diseases
Key Trends and Developments:
- Technological Advancements: Introduction of new technologies and products in molecular diagnostics.
- Market Growth Drivers: Factors contributing to the growth of the molecular diagnostics market, including increased demand for high sensitivity and specificity in infectious disease testing.
- Competitive Landscape: Analysis of leading industry players and their strategies, including expansions, acquisitions, and product launches.
For further details and to purchase directly, please contact us.
Sample Report: A sample is available as a PDF upon request.
Table: Molecular Diagnostic Market, by Category, 2021-2026 ($ millions)
Segment | 2021 | 2026 | CAGR (%) |
Infectious: | |||
HAIs/ sepsis | $XX Millions | $XX Millions | XX% |
Hepatitis | $XX Millions | $XX Millions | XX% |
HIV | $XX Millions | $XX Millions | XX% |
STIs | $XX Millions | $XX Millions | XX% |
Respiratory | $XX Millions | $XX Millions | XX% |
TB | $XX Millions | $XX Millions | XX% |
Total Infectious, non COVID | $XX Millions | $XX Millions | XX% |
Oncology: | |||
Cancer Assays* | $XX Millions | $XX Millions | XX% |
Histology (ISH, FISH) | $XX Millions | $XX Millions | XX% |
Molecular HPV | $XX Millions | $XX Millions | XX% |
Total Oncology | $XX Millions | $XX Millions | XX% |
NAT Blood Screening | $XX Millions | $XX Millions | XX% |
Genetic: | |||
NIPT | $XX Millions | $XX Millions | XX% |
Thrombophilia/SNPs | $XX Millions | $XX Millions | XX% |
Pharmacogenomics | $XX Millions | $XX Millions | XX% |
Inherited/Rare | $XX Millions | $XX Millions | XX% |
Total Genetic | $XX Millions | $XX Millions | XX% |
Transplantation | $XX Millions | $XX Millions | XX% |
TOTAL | $XX Millions | $XX Millions | XX% |
COVID | $XX Millions | $XX Millions | XX% |
Total Market w COVID | $XX Millions | $XX Millions | XX% |
Source: Kalorama Information